You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 139 No. 5, May 2004 TABLE OF CONTENTS
  Archives
  •  Online Features
  Paper
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (13)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Endocrine Surgery
 •Prognosis/ Outcomes
 •Alert me on articles by topic

Outcome of Laparoscopic Adrenalectomy for Pheochromocytomas vs Aldosteronomas

Anthony W. Kim, MD; Roderick M. Quiros, MD; Justin B. Maxhimer, BA; Abdel R. El-Ganzouri, MD; Richard A. Prinz, MD

Arch Surg. 2004;139:526-531.

Hypothesis  Laparoscopic adrenalectomy (LA) is most commonly performed for pheochromocytomas (PHEs) and aldosteronomas (ALDs). We hypothesize that LA for these differing tumor types is associated with different operative courses and outcomes.

Design  Retrospective study of a 10-year experience with LA.

Setting  University teaching hospital.

Patients  Laparoscopic adrenalectomy was performed on 149 patients. During data analysis, the initial 35 LAs performed for various adrenal lesions were excluded to account for the learning curve. Twenty-six of 30 PHEs and 34 of 45 ALDs were included.

Main Outcome Measures  Analysis of variance was used to compare operative time, tumor size, estimated blood loss, and postoperative length of hospital stay between the PHE and ALD groups and subsets of these groups. {chi}2 Analysis was used to compare tumor location, transfusion requirements, conversion to open procedures, and incidence of major complications.

Results  Right-sided lesions occurred in 19 of 26 PHEs, and left-sided lesions occurred in 28 of 34 ALDs (P <.001). Mean ± SD tumor size of PHEs (4.9 ± 1.8 cm) was larger than that of ALDs (2.7 ± 1.7 cm) (P <.001). Mean ± SD operative time for PHEs vs ALDs was 191 ± 49 vs 162 ± 48 minutes (P = .02). Mean ± SD estimated blood loss was greater for PHEs (276 ± 298 mL) than for ALDs (196 ± 324 mL) (P = .33). Subset analysis revealed that the mean ± SD size of right-sided PHEs (5.3 ± 1.8 cm) was significantly larger than that of right-sided ALDs (3.0 ± 1.5 cm) (P=.001). Mean ± SD operative time for right-sided PHEs (198 ± 44 minutes) was longer than that for right-sided ALDs (145 ± 37 minutes) (P=.005). Six PHE patients required blood transfusions vs 2 ALD patients (P = .05). Two LAs, 1 PHE and ALD, were converted to open procedures. Mean ± SD length of hospital stay was longer for PHE patients vs ALD patients (4 ± 4 vs 2 ± 3 days; P = .08). Six PHE patients had complications vs 3 ALD patients (P = .13).

Conclusions  For PHEs, LA was associated with the removal of more right-sided lesions, larger tumors, longer operative times, and more complications. Trends toward greater estimated blood losses and longer hospital stays were observed for PHEs vs ALDs. Despite the advanced skills of an experienced surgeon, LA for PHEs is associated with a more complex course than for ALDs. Surgeons should begin performing LA for ALD early in their experience to avoid the potential pitfalls associated with PHEs.


From the Departments of General Surgery (Drs Kim, Quiros, and Prinz and Mr Maxhimer) and Anesthesiology (Dr El-Ganzouri), Rush University Medical Center, Chicago, Ill.


RELATED ARTICLE

This Month in Archives of Surgery
Arch Surg. 2004;139(5):465.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Outcomes of Pheochromocytoma Management in the Laparoscopic Era
Solorzano et al.
Ann. Surg. Oncol. 2007;14:3004-3010.
ABSTRACT | FULL TEXT  

[11C]Metahydroxyephedrine and [18F]Fluorodeoxyglucose Positron Emission Tomography Improve Clinical Decision Making in Suspected Pheochromocytoma
Mann et al.
Ann. Surg. Oncol. 2006;13:187-197.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.